COVID-19
As another wave of COVID-19 emerges, we’ve updated this page to present the latest information.
- Consult your healthcare team for tailored advice as we learn more about COVID-19.
- We will update this page, a central point for patients, with new COVID-19 information from experts.
Consider essential precautions and measures
Frequently asked questions
What does it mean to be "immunocompromised"?
Why are transplant recipients considered more vulnerable to illnesses like COVID?
What are the recommended precautions immunocompromised people should take to protect against coronavirus?
Actions you can take to protect yourself and others include:
- Staying up to date with your COVID-19 vaccines
- Wearing a well-fitting mask
- Avoiding crowds and poorly ventilated spaces
- Test to prevent the spread to others
- Washing your hands often
- Cover coughs and sneezes
- Monitor your health daily
- Talk with your transplant team about other preventative treatment options
Vaccine questions
Is a COVID-19 vaccination required in order to receive an organ transplant?
Are there any ongoing concerns about the impact of COVID on fully-vaccinated transplant recipients?
Can I still be a living organ donor if I have/have not received a COVID-19 vaccine?
General questions
Are organ donors tested for COVID-19? Can those who have had or currently have COVID-19 still donate? What about donors who have had or currently have “long COVID”?
The OPTN Disease Transmission Advisory Committee has developed donor testing guidance for professionals. The guidance is regularly updated.
While people who have active COVID are not generally considered as donors, in some rare cases, transplants from COVID-positive donors have been performed. These have taken place in limited numbers and on a case-by-case basis after careful assessment of the risks and benefits by clinicians and potential recipients.
Long COVID is a variety of symptoms that persist following resolution of an active COVID infection. Long COVID is not an active COVID infection.
As with all potential donors, following thorough testing, if the organs from a deceased donor who experienced long COVID are found to be suitable for transplant, they can be considered for transplantation on a case-by-case basis.
Are transplant programs changing appointments/clinics/lab tests due to COVID-19?
What happens if I am temporarily put in an inactive status? Do I lose any priority on the waiting list?
A temporary inactivation does not mean that you are removed from the waiting list. It means that for a period of time determined by the transplant program, you would not be considered for organ offers. The transplant program may reactivate you at any time they believe they can resume transplanting patients as usual.
If you are awaiting a kidney and/or pancreas transplant, or if you have a child younger than age 12 needing a lung transplant, the priority you accrue based on waiting time will continue as long as you remain inactive. When you are reactivated you will keep all the waiting time you have gained.
If you need a different organ type, or you are a lung candidate older than age 12, you only accrue waiting time while you are in an active listing category. In this case, your transplant program may temporarily change the criteria for organ offers you might receive. That will allow you to remain active and continue to gain waiting time. You would, however, not be considered for organ offers until the program resets the criteria.
Your transplant program can discuss with you your current status and any conditions where they believe it is best to not accept organ offers for you for a limited time.
If my relative or friend needs a transplant, or just had a transplant, can I visit them at home or in the hospital?
In general, you should follow current medical recommendations for masking and social distancing. CDC is continually updating its COVID-19 resource page with guidance and information. If you have specific questions about contact, your friend or loved one’s transplant team may offer more guidance.
Keep in mind that all transplant recipients take medicine to prevent organ rejection. That same medication may lower their normal immune response to common illnesses. People who have recently had an organ transplant often are on higher doses of these medications and must take additional precautions to lower their risk of infection.
Even if you are unable to visit them close and in person, you can continue to show your support and caring by sending them a card or gift, a call or video chat, or supporting them on social media.
Resources
Explore HHS guidelines
The U.S. Department of Human Services’ (HHS) agencies (FDA, NIH and CDC) have unveiled an updated strategy to address COVID-19. The current vaccines are expected to provide protection against COVID-19 from the currently circulating variants, according to the Food and Drug Administration (FDA).
- FDA approved COVID-19 vaccines from Pfizer, Moderna and Novovax.
- National Institutes of Health’s (NIH) special clinical considerations outline risks for transplant patients, including how immunosuppressive medication regimens should be uniquely tailored, factoring in disease severity, risk of graft rejection, medication types, time since the transplant, drug concentration, and potential drug interactions.